Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01844583 |
| Title | Safety, Tolerability and PK of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Millennium Pharmaceuticals, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Sarasota | Florida | United States | Details | |||
| Saint Louis | Missouri | United States | Details | |||
| Oklahoma City | Oklahoma | United States | Details | |||
| Nashville | Tennessee | United States | Details | |||
| Dallas | Texas | United States | Details | |||
| San Antonio | Texas | United States | Details | |||
| Madison | Wisconsin | United States | Details |